Mithra

Mithra (Euronext: MITRA) is a Belgian biotech company, headquartered in Liège, dedicated to transforming Women’s Health by offering new choices through innovation, with a focus on contraception and menopause. For over 20 years, our goal has been to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their entire lifespan. Mithra explores the potential of the unique native estrogen Estetrol in a wide range of applications in women health and beyond. After having successfully launched our first Estetrol-based product in 2021, the contraceptive pill Estelle, Mithra is now focusing on its second product Donesta®, the next-generation hormone therapy. Additionally, we develop and manufacture complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers at our technological platform: Mithra CDMO. A facility and expertise that allows us to offer partners a complete spectrum of research, development and specialist manufacturing. To lead and achieve innovation in over 100 countries worldwide, we can rely on our consistently growing 300 staff members. www.mithra.com